Kalpataru Multiplier Ltd.

Our Bank & DP Click for Online Payment MF portfolio login smart way to invest in gold
Sovereign gold bond(SGB) Exchange trades funds(ETF)
CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

Company Profile
more from company profile
HomeMarkets Company Profile Smart Quotes

Smart Quotes

CAPLIN POINT LABORATORIES LTD.

NSE : CAPLIPOINTBSE : 524742ISIN CODE : INE475E01026Industry : Pharmaceuticals & DrugsHouse : Private
BSE2596.45199.4 (+8.32 %)
PREV CLOSE () 2397.05
OPEN PRICE () 2416.80
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 24692
TODAY'S LOW / HIGH ()2383.00 2636.00
52 WK LOW / HIGH ()1221 2636
NSE2600.15201.05 (+8.38 %)
PREV CLOSE() 2399.10
OPEN PRICE () 2400.00
BID PRICE (QTY) 2600.15 (2932)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 840106
TODAY'S LOW / HIGH() 2381.15 2641.00
52 WK LOW / HIGH ()1225 2641
BSE NSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1990

Management Info :

C C Paarthipan - Chairman Sridhar Ganesan - Managing Director

Registered Office :

Address : 3rd Floor, “ Ashvich Towers”,No.3, Developed Plots Industrial Estate,Perungudi,
Chennai,
Tamil Nadu-600096

Phone : 044-24968000 / 8012772888 / 71148000

Registrar's Details : Integrated Registrary Management Services Pvt Ltd.-(Formerly Integrated Enterprises (India) Ltd)
II Floor , Kences Towers,No 1 Ramakrishna Street,North Usman Road, T Nagar,Chennai
Listing : BSE, NSE
NEWS
16Dec Caplin Point Laboratories’ arm gets US
Caplin Point Laboratories’ subsidiary -- Caplin Steriles has been grante..
16Dec Caplin Point Laboratories informs abou
Caplin Point Laboratories has attached a Press Release regarding grant o..
12Dec Caplin Point Laboratories informs abou
Caplin Point Laboratories has informed that share certificates have been..
15Nov Caplin Point Laboratories informs abou
Caplin Point Laboratories has informed that share certificates has been..
10Oct Caplin Point Laboratories informs abou
Caplin Point Laboratories has submitted a certificate under Regulation 7..
Financials
in Millions
QTR Sep 24 ANNUAL 24
Net Profit1057.42837.1
Gross Profit 1346.6 3657.4
Operating Profit 1411.73929.2
Net Sales 2079.36250.9
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Abbott India (BSE)
 29300.05 (2.33%)
M.Cap ( in Cr)
62260.56
Neuland Laboratories (BSE)
 13712.60 (1.98%)
M.Cap ( in Cr)
17593.11
Ajanta Pharma (BSE)
 3039.45 (8.73%)
M.Cap ( in Cr)
37966.41
Alkem Laboratories (BSE)
 5481.75 (1.43%)
M.Cap ( in Cr)
65542.54
Akums Drugs & Pharmaceuticals (BSE)
 668.10 (9.99%)
M.Cap ( in Cr)
10515.49
Shareholding Pattern
PROMOTERS 70.56%
NON-INSTITUTION 23.91%
MUTUAL FUNDS/UTI 1.62%
FI/BANKS/INSURANCE 0.15%
GOVERNMENT 0%
FII 0%
Mf Holding
ATTENTION INVESTORS

Kalpataru Multiplier Ltd.

Kalpataru is a wishful Divine Tree and in present context a widely Trusted, Time tested and Transparent Share Broker, Mutual Fund Distributor and D.P. of this region.

Mobile Trading App
Mobile Trading IOS App
Call Us 0755-4350141/142/143, 9425008895
Mutual Funds 0755-4276725, 4276726
Email Uskmlho@kalpatarumulti.com

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalparatu Multiplier Ltd.
Designed ,Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.
SENSEX78699.07226.59 (0.29%)
NIFTY23813.4063.20 (0.27%)
Dow Jones 42992.21-333.59 (-0.77%)
Nasdaq 19722.03-298.33 (-1.49%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI